Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis

Arquivos de neuro-psiquiatria
Vanessa Daccach MarquesJefferson Becker

Abstract

The expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective and personalized treatment, but the choice and management of disease-modifying therapies (DMTs) is becoming increasingly complex. In this context, experts from the Brazilian Committee on Treatment and Research in Multiple Sclerosis and the Neuroimmunology Scientific Department of the Brazilian Academy of Neurology have convened to establish this Brazilian Consensus for the Treatment of MS, based on their understanding that neurologists should be able to prescribe MS DMTs according to what is better for each patient, based on up-to-date evidence and practice. We herein propose practical recommendations for the treatment of MS, with the main focus on the choice and management of DMTs, as well as present a review of the scientific rationale supporting therapeutic strategies in MS.

References

Jan 1, 1988·Archives of Neurology·J M KillianD P Huston
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
Apr 26, 2001·Multiple Sclerosis : Clinical and Laboratory Research·N A LosseffA J Thompson
May 30, 2001·Lancet·G ComiUNKNOWN Early Treatment of Multiple Sclerosis Study Group
Sep 6, 2001·Journal of the Neurological Sciences·R BergamaschiV Cosi
Dec 31, 2002·Lancet·Hans-Peter HartungUNKNOWN Mitoxantrone in Multiple Sclerosis Study Group (MIMS)
Jul 27, 2005·Journal of Neurology·Alasdair J ColesD Alastair Compston
Mar 3, 2006·The New England Journal of Medicine·Chris H PolmanUNKNOWN AFFIRM Investigators
Jan 22, 2008·Journal of Neurology·Claire HirstNeil Robertson
Jan 23, 2008·Multiple Sclerosis : Clinical and Laboratory Research·Helen TremlettVirginia Devonshire
Jan 29, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·S DeenE Waubant
Feb 15, 2008·The New England Journal of Medicine·Stephen L HauserUNKNOWN HERMES Trial Group
Jun 20, 2008·Multiple Sclerosis : Clinical and Laboratory Research·J RíoX Montalban
Aug 8, 2008·Acta Neurologica Scandinavica·M VercellinoP Cavalla
Oct 4, 2008·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giancarlo Comi
Aug 22, 2008·Journal of the Neurological Sciences·Edgar MeinlReinhard Hohlfeld
Dec 11, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·E M MowryE Waubant
Jan 22, 2010·The New England Journal of Medicine·Ludwig KapposUNKNOWN FREEDOMS Study Group
Jan 22, 2010·The New England Journal of Medicine·Gavin GiovannoniUNKNOWN CLARITY Study Group
Apr 7, 2010·Clinical Neurology and Neurosurgery·Reza Vosoughi, Mark S Freedman
Apr 29, 2010·Brain : a Journal of Neurology·Emmanuelle LerayGilles Edan
Jun 11, 2010·Brain : a Journal of Neurology·Antonio ScalfariGeorge C Ebers
Aug 26, 2011·Multiple Sclerosis : Clinical and Laboratory Research·M CossburnN P Robertson
Sep 16, 2011·Neurology·A ScalfariP A Muraro
Oct 14, 2011·The New England Journal of Medicine·Paul O'ConnorUNKNOWN TEMSO Trial Group
Jun 20, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Inger BoströmAnne-Marie Landtblom
Jul 11, 2012·Current Neurology and Neuroscience Reports·Jorge CorrealeMarcela P Fiol
Sep 21, 2012·The New England Journal of Medicine·Robert J FoxUNKNOWN CONFIRM Study Investigators
Sep 21, 2012·The New England Journal of Medicine·Ralf GoldUNKNOWN DEFINE Study Investigators
Oct 18, 2012·Journal of the Neurological Sciences·Alfredo DamascenoFernando Cendes

❮ Previous
Next ❯

Citations

Jul 18, 2019·Arquivos de neuro-psiquiatria·Renan Barros DominguesCarlos Senne
Dec 31, 2019·Journal of the Neurological Sciences·Wildéa Lice de Carvalho Jennings PereiraEdna Maria Vissoci Reiche
Feb 24, 2021·Journal of Comparative Effectiveness Research·Imtiaz A SamjooNicholas Adlard
Aug 29, 2020·Mycopathologia·Eliana Tomomi Shimabukuro da CunhaJuliana Campos Junqueira
Sep 2, 2021·Arquivos de neuro-psiquiatria·Cássia Elisa MarinJefferson Becker
Nov 9, 2021·The Cochrane Database of Systematic Reviews·Graziella FilippiniCinzia Del Giovane

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia. Departamento Científico de Neuroimunologia
BMJ : British Medical Journal
Floriana De AngelisWallace J Brownlee
© 2022 Meta ULC. All rights reserved